0 participants
Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-20
- Start Date:
- 2024-07-30
- Completion:
- 2024-10-02
Conditions
- Recurrent Glioblastoma
Interventions
- DRUG
- DEVICE
No Results Yet